SightfileU.S. market data from official filings

Companies › ONMD

ONEMEDNET CORP (ONMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001849380 · EDGAR filings · Updated 2026-07-24

ONEMEDNET CORP (ONMD) has reported institutional ownership of 20.6%, with 21 institutional managers holding positions valued at $9.15M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
20.6%
Institutional managers
21
Reported 13F value
$9.15M
Insider activity
108 trans.
$1.86M net buying
Data flags
3 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ONEMEDNET CORP has 21 institutional holders and institutional ownership of 20.6%.

Insider activity

Insiders reported 108 transactions (74 buys, 2 sells) across 9 reporting insiders, with a net reported value of $1.86M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2021-06-21) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2026-04-20 (recurring since 2024-02-09) — source filing. The authoritative details are those stated in the filing itself.
Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2024-11-05 (recurring since 2021-11-19) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Pasithea Therapeutics Corp (KTTA) · Boundless Bio Inc (BOLD) · CYTOSORBENTS CORP (CTSO) · CITIUS ONCOLOGY INC COM (CTOR) · Entera Bio Ltd (ENTX) · IMMUCELL CORP (ICCC)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.